MiR-199a/b-5p was reported to inhibit the activation of the ROCK1/MLC and PI3K/Akt signaling pathways by negatively regulating ROCK1 expression, leading to the inhibition of liver cancer metastasis (23). Here, AKT1 is linked to liver cancer.